Why risky Alzheimer's research investing persists

Alzheimer's research suffered a public blow this week with the CEO of French firm Sanofi saying investment in the disease isn't worth the risk.

http://www.bizjournals.com/triangle/morning_call/2013/04/why-risky-alzheimers-research.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_triangle+%28Triangle+Business+Journal%29